NetworkNewsBreaks

ThursdayFeb 13, 2020 1:29 pm

NetworkNewsBreaks – SinglePoint, Inc. (SING) Provides Update on Bullish Outlook for Upcoming Solar+ Decade and the Future of Energy in America

SinglePoint (OTCQB: SING) today provided an update on the bullish outlook for 2020 and beyond for solar and renewable energy and its acquisition of Direct Solar America, a unique and scalable national solar energy brokerage focused on finding and arranging installation of the best available solar energy system for any residential home or commercial building. According to the update, revenues and coverage has expanded in a little over six months since the acquisition, firmly establishing the company’s footprint in the solar sector, which is predicted to continue to grow throughout the next decade. National trade association of the U.S., Solar…

Continue Reading

ThursdayFeb 13, 2020 12:43 pm

NetworkNewsBreaks – Akoustis Technologies, Inc. (NASDAQ: AKTS) Featured in ROTH Equity Research Report

Akoustis Technologies (NASDAQ: AKTS) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “We regard AKTS as an emerging vendor of RF filters for the smartphone, WiFi, infrastructure and defense markets. AKTS’ revenue guidance reflects expectation for volume filter revenue ramp in the mid-to-late CY20 timeframe. However, AKTS remains comfortable that revenue growth and volume production ramp can be supported by multiple end market programs from several Tier-1 customers. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Akoustis Technologies, Inc. Akoustis(R) is a high-tech BAW…

Continue Reading

ThursdayFeb 13, 2020 12:38 pm

NetworkNewsBreaks – Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in ROTH Equity Research Report

Fortress Biotech (NASDAQ: FBIO) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “This is a weekly update tracking prescriptions for FBIO's Ximino launch (extended release minocycline capsule for the treatment of acne). Total prescriptions decreased to 2,083 from 2,365 last week. Overall, we viewed this week's data as noise given the Martin Luther King Jr. holiday celebrated on January 20th. Maintain Buy rating with a price target of $4.00/share.” To request access to the full report, visit http://nnw.fm/DXCr3 About Fortress Biotech Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company that…

Continue Reading

ThursdayFeb 13, 2020 12:24 pm

NetworkNewsBreaks – Atomera, Inc. (NASDAQ: ATOM) Featured in ROTH Equity Research Report

Atomera (NASDAQ: ATOM) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “We regard ATOM as a highly differentiated silicon enhancement IP vendor that is gaining traction with large semiconductor supply chain companies. We believe the company continues to make solid progress across its significant base of engagements. We expect ATOM to continue to convert additional engagements to licensing revenue over the next few quarters. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Atomera Inc. Atomera has developed Mears Silicon Technology(TM) ("MST"), which increases performance…

Continue Reading

ThursdayFeb 13, 2020 12:20 pm

NetworkNewsBreaks – aTyr Pharma, Inc. (NASDAQ: LIFE) Secures $18 Million in Underwritten Public Offering

aTyr Pharma (NASDAQ: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, has closed an underwritten public offering of 4,235,294 shares of its common stock. According to the update, the shares were each sold at the public offering price of $4.25, resulting in approximately $18 million in proceeds for aTyr Pharma. In addition, aTyr Pharma has granted the underwriters a 30-day option to purchase up to an additional 635,294 shares of common stock in connection with the public offering. ROTH Capital Partners acted as lead manager for the offering. To view…

Continue Reading

ThursdayFeb 13, 2020 11:43 am

NetworkNewsBreaks – InnerScope Hearing Technologies (INND) Announces Launch of Hearing and Tinnitus Dietary Supplements on Sears.com

InnerScope Hearing Technologies (OTC: INND), a manufacturer and Direct-to-Consumer ("DTC") distributor/retailer of FDA-registered hearing aids, personal sound amplifiers products, hearing related treatment therapies, doctor-formulated dietary hearing & tinnitus supplements, proprietary CBD oil for tinnitus and assorted ear & hearing aid related supplies (collectively "hearing product portfolio"), today announced the launch of its complete line of "Nutrition for the Ears" doctor-formulated dietary hearing and tinnitus supplements on Sears.com. According to the update, the supplement formulations are specifically designed with a proprietary blend of vitamins, minerals and nutrients that medical research indicated may slow the progression of age-related hearing loss and help…

Continue Reading

ThursdayFeb 13, 2020 10:58 am

NetworkNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Announces Reshaping of its Board of Directors

Youngevity International (NASDAQ: YGYI), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise and its newly acquired commercial hemp enterprise, today announced the reshaping of its Board of Directors. According to the update, effective February 11, 2020, in order to maintain compliance with The Nasdaq Capital Market’s corporate governance requirements and, specifically, Listing Rule 5605(b) which provides that a listed company's board of directors shall be comprised of a majority of independent directors, Michelle Wallach and Richard Renton, two non-independent members of the Board of Directors of YGYI resigned as members of the Board…

Continue Reading

ThursdayFeb 13, 2020 10:51 am

NetworkNewsBreaks – Endonovo Therapeutics, Inc. (ENDV) Collaborates with a Stanford University Sponsored Orthopedic Shoulder and Knee Study

Endonovo Therapeutics (OTCQB: ENDV) today announced its collaboration with a Stanford University sponsored Orthopedic Shoulder and Knee Study to determine benefits of Endonovo's tPEMF SofPulse(R) on pain, medication levels and physical function post-operatively. According to the update, the study will evaluate 76 patients with Active and Sham Comparator groups, measured by visual analog scale (“VAS”), at 10 days after, and will allow surgeons to determine postoperative efficacy of Endonovo's SofPulse(R) tPEMF portable device. “The study will allow surgeons to determine if PEMF SofPulse(R) therapy is beneficial in reducing patient-reported post-operative pain,” Endonovo CMO, Dr. Nev Zubcevik DO, said in the…

Continue Reading

ThursdayFeb 13, 2020 10:09 am

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH(TM)-Enabled CBD Infused Powders Available for Sale Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that its DehydraTECH(TM)-enabled CBD infused powders are now available for sale across the U.S. to businesses wanting to produce topicals and edibles with clinically proven performance for increased consumer satisfaction and improved stability. Consumers of both CBD/hemp and cannabis have recently become concerned about the potency and safety of the oil extract products they are purchasing. Lexaria's patented DehydraTECH(TM) technology and powder processing methodology, similar to a pasteurization technique in some ways, helps to not only preserve cannabinoid potency but also to reduce or eliminate…

Continue Reading

ThursdayFeb 13, 2020 9:58 am

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Reveals Results from New BIGresearch Valentine’s Day Report

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, this morning released results from its BIGresearch study. The study of over 53,000 Americans was conducted in January 2020 and the results uncover this year's Valentine's Day consumer behaviors and opinions. Among other highlights, the study found that 79% of people celebrating this year are between the ages of 18 and 34, with 47% between 25 and 34. The report also includes detailed information based on shopping surveys, with results broken out by gender, age, household income, and ethnicity. “Changing values and opinions in consumers greatly affect their…

Continue Reading